Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

PHAR 100 Exam – Real Exam Questions and Correct Answers, Exams of Pharmacology

PHAR 100 Exam – Real Exam Questions and Correct Answers

Typology: Exams

2024/2025

Available from 07/11/2025

lec-douglas-levis
lec-douglas-levis 🇺🇸

121 documents

1 / 38

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
PHAR 100 Exam – Real Exam Questions and Correct Answers (Verified) University of
California, San Francisco (UCSF) A+ Grade
Who |discovered |morphine? |- |answersSerturner
From |what |drug |was |ephedrine |isolated? |- |answersMa |Huang
What |does |ephedrine |treat? |- |answersasthma
What |are |the |two |uses |of |curare? |- |answers1. |Poison: |used |on |arrow |tips |to |cause |muscle |paralysis |
and |death |by |respiratory |paralysis
2. |Drug: |anesthetics |during |surgery |to |relax |muscles
What |is |Ergot? |- |answersa |poisonous |fungus |that |grows |on |the |heads |of |rye, |especially |during |wet |
seasons
What |is |the |potent |substance |of |peyote? |- |answersmescaline
What |are |the |effects |of |peyote? |- |answershallucinations, |a |feeling |of |well-being, |and |distortion |of |
perception |similar |to |that |of |LSD
Is |zinc |oxide |found |in |many |topical |creams |today? |- |answersyes
What |is |a |drug? |- |answersany |substance |received |by |a |biological |system |that |is |not |received |for |
nutritive |purposes |and |which |influences |the |biological |function |of |the |organism
What |are |the |two |major |categories |of |drugs |discovered |throughout |history? |- |answers1. |drugs |that |
act |on |the |brain
2. |drugs |that |act |against |infectious |disease
Drugs |that |act |on |the |brain |alter |_____. |- |answersthe |normal |chemical |signalling |in |the |brain
What |is |an |example |of |a |drug |that |acts |on |the |brain? |- |answersLSD
Who |synthesized |LSD? |When? |- |answersAlbert |Hoffman |in |1943
LSD |is |similar |in |chemical |structure |to |___ |and |____. |- |answersergotamine |and |ergonovine
What |is |an |infectious |disease? |- |answersany |disease |caused |by |an |organism, |such |as |bacteria, |viruses,
|fungi, |or |parasites
What |is |an |organoarsenical |and |what |does |it |cure? |- |answers- |a |complex |or |arsenic |and |organic |
molecules |that |selectively |bind |to |parasites
- |cures |syphillis
Who |and |when |developed |Organoarsenicals? |- |answersPaul |Ehrlich |in |the |1900s
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26

Partial preview of the text

Download PHAR 100 Exam – Real Exam Questions and Correct Answers and more Exams Pharmacology in PDF only on Docsity!

PHAR 100 Exam – Real Exam Questions and Correct Answers (Verified) University of

California, San Francisco (UCSF) A+ Grade

Who |discovered |morphine? |- |answersSerturner From |what |drug |was |ephedrine |isolated? |- |answersMa |Huang What |does |ephedrine |treat? |- |answersasthma What |are |the |two |uses |of |curare? |- |answers1. |Poison: |used |on |arrow |tips |to |cause |muscle |paralysis | and |death |by |respiratory |paralysis

  1. |Drug: |anesthetics |during |surgery |to |relax |muscles What |is |Ergot? |- |answersa |poisonous |fungus |that |grows |on |the |heads |of |rye, |especially |during |wet | seasons What |is |the |potent |substance |of |peyote? |- |answersmescaline What |are |the |effects |of |peyote? |- |answershallucinations, |a |feeling |of |well-being, |and |distortion |of | perception |similar |to |that |of |LSD Is |zinc |oxide |found |in |many |topical |creams |today? |- |answersyes What |is |a |drug? |- |answersany |substance |received |by |a |biological |system |that |is |not |received |for | nutritive |purposes |and |which |influences |the |biological |function |of |the |organism What |are |the |two |major |categories |of |drugs |discovered |throughout |history? |- |answers1. |drugs |that | act |on |the |brain
  2. |drugs |that |act |against |infectious |disease Drugs |that |act |on |the |brain |alter |_____. |- |answersthe |normal |chemical |signalling |in |the |brain What |is |an |example |of |a |drug |that |acts |on |the |brain? |- |answersLSD Who |synthesized |LSD? |When? |- |answersAlbert |Hoffman |in | 1943 LSD |is |similar |in |chemical |structure |to |___ |and |____. |- |answersergotamine |and |ergonovine What |is |an |infectious |disease? |- |answersany |disease |caused |by |an |organism, |such |as |bacteria, |viruses, |fungi, |or |parasites What |is |an |organoarsenical |and |what |does |it |cure? |- |answers- |a |complex |or |arsenic |and |organic | molecules |that |selectively |bind |to |parasites
  • |cures |syphillis Who |and |when |developed |Organoarsenicals? |- |answersPaul |Ehrlich |in |the |1900s

Who |and |when |developed |Sulla |drugs? |- |answersGerard |Domagk |in |the |1930s Who |and |when |discovered |Penicillin? |- |answersAlexander |Fleming |in |the |1940s Who |and |when |discovered |streptomycin? |- |answersSeaman |Waksman |in |the |1950s What |are |the |five |key |steps |of |drug |development? |- |answers1. |basic |research |and |drug |discovery

  1. |preclinical |trials
  2. |clinical |trials
  3. |health |Canada |review |and |manufacturing
  4. |post-market |surveillance |and |phase | 4 |clinical |trials What |are |the |two |steps |of |basic |drug |research? |- |answers1. |identification |of |the |target
  5. |studying |the |target What |is |a |lead |compound? |- |answersa |compound |that |shows |promise |in |the |initial |studies |and |will | enter |more |detailed |studies What |are |the |two |categories |of |preclinical |studies? |- |answers- |pharmacology: |determines |the |detailed |mechanism |of |action |of |the |new |drug |
  • |toxicology: |determines |the |potential |risks |of |the |drug What |are |the |initial |steps |of |clinical |trials? |- |answers1. |proof |of |safety
  1. |methodology
  2. |investigation Target |Population |- |answersthe |group |of |patients |for |whom |the |drug |is |intended Study |Population |- |answersa |subset |of |the |target |population |that |meets |all |required |criteria Inclusion/Exclusion |Criteria |- |answersdefines |characteristics |of |the |patients |to |be |included |in |the | study, |determining |who |is |and |who |is |not |eligible |for |the |trial Consent |- |answersa |document |written |in |non-scientific |language |that |outlines |the |purpose |of |the | study, |etc |must |be |obtained |before |a |person |can |participate Double |Blind |Design |- |answerswhere |neither |the |investigator |nor |the |study |subject |is |aware |of |the | treatment |the |study |subject |is |assigned |to Randomization |- |answerspatients |are |assigned |to |the |experimental |treatment |group |or |a |control | group, |usually |by |computer |generation What |are |the |two |types |of |control? |- |answers- |placebo
  • |gold |standard

What |does |enteral |route |of |administration |refer |to? |- |answersAdministration |via |the |GI |tract, |either | through |the |mouth |or |an |artificial |opening What |is |the |first |pass |effect? |- |answersWhen |the |drug |is |first |delivered |to |the |liver, |which |contains | enzymes |that |can |decrease |the |amount |of |active |drug |left |to |enter |the |general |circulation What |is |parental |route |of |administration? |- |answersWhen |it |bypasses |the |GI |tract |by |being |injected | into |the |body |and |enter |the |bloodstream |directly What |are |three |parental |routes? |- |answersIntravenous, |intramuscular, |subcutaneous Bioavailability |- |answersThe |fraction |of |an |administered |dose |that |reaches |the |systemic |circulation |in | an |active |form What |are |the | 3 |methods |of |absorption? |- |answers1. |Diffusion |through |aqueous |pores

  1. |Diffusion |through |lipids
  2. |Active |transport P450 |- |answersenzymes |capable |of |biotransforming |drugs Phase | 1 |of |biotransformation |reactions |- |answersTo |add |or |unmask |a |functional |group |on |the |drug |to |prepare |it |for |the |addition |of |a |large |water-soluble |molecule |in |phase | 2 Phase | 2 |of |biotransformation |reactions |- |answersAdd |a |large |water-soluble |moiety |(glucaronic |acid |or |sulfate) |to |the |phase | 1 |product, |making |it |water-soluble |for |excretion |by |the |kidney Where |are |the |majority |of |drugs |eliminated? |- |answersKidney Adverse |drug |reaction |- |answersAny |effect |produced |by |a |drug |in |a |patient |that |is |not |the |intended | effect True |or |false? |A |drug |cannot |cause |effects |that |are |unrelated |to |the |intended |pharmacological |action | of |the |drug. |- |answersFalse What |mediates |an |allergic |reaction? |- |answersImmune |system Teratogenesis |- |answersWhen |a |drug |produces |defects |in |a |developing |fetus What |are | 4 |factors |in |predicting |adverse |drug |reactions? |- |answers- |rarity |of |occurrence
  • |length |of |usage
  • |detectability |in |animals
  • |time |period |specificity What |is |the |therapeutic |index? |- |answersTells |you |how |safe |the |drug |is |by |relating |the |dose |of |the | drug |required |to |produce |a |beneficial |effect |to |the |dose |required |to |produce |an |adverse |effect True |or |false? |The |higher |the |therapeutic |index, |the |safer |the |drug. |- |answersTrue TD50 |- |answersDose |of |the |drug |that |is |toxic |in |50% |of |the |population

ED50 |- |answersDose |of |the |drug |that |is |effective |in |50% |of |the |population Drug-food |interactions |- |answersThe |interference |of |food |with |drugs |taken |concurrently Where |is |tyramine |found? |- |answersWell |matured |cheese Tyramine |is |capable |of |____________ |and |is |broken |down |by________. |- |answers- |raising |blood | pressure

  • |by |monoamine |oxidase |(MAO) |in |the |liver Can |grapefruit |alter |the |absorption |of |some |drugs? |- |answersYes Why |is |grapefruit |not |served |in |ontario |hospitals? |- |answersBecause |a |component |of |grapefruit | inhibits |enzymes |that |metabolize |drugs |in |the |GI |tract, |which |leads |to |a |greater |amount |of |the |active | drug |being |absorbed, |which |leads |to |higher |blood |levels |of |the |drug, |leading |to |possible |overdose What |are |the |overall |functions |of |the |cerebral |cortex? |- |answers- |sensory/motor |coordination |
  • |mental |processes
  • |intelligence
  • |memory,
  • |vision
  • |judgement
  • |thought
  • |speech
  • |emotions
  • |consciousness What |are |of |the |brain |controls |emotion |and |behaviour? |- |answersThe |limbic |system |with |the | hypothalamus Neurogenesis |- |answersHow |new |neurons |are |generated Neuroplasticity |- |answersThe |connection |between |neurons |constantly |getting |reshaped What |is |the |primary |excitatory |neurotransmitter |in |the |CNS? |- |answersGlutamate Dopamine |and |norepinephrine |are |considered |what? |- |answersCatecholamines What |pathways |are |related |to |the |control |of |hormonal |systems, |motor |coordination, |and |motivation | and |reward? |- |answersDopaminergic What |is |the |primary |inhibitory |neurotransmitter |in |the |CNS? |- |answersgamma |amino |butyric |acid | (GABA) Does |acetylcholine |produce |an |inhibitory |or |excitatory |response |in |the |CNS? |- |answersExcitatory
  • |diarrhea
  • |abdominal |cramping
  • |vomiting Cross |tolerance |- |answersThe |resistance |or |tolerance |to |one |drug |because |of |the |resistance |or | tolerance |to |a |pharmacologically |similar |drug Harm |reduction |- |answersAn |approach |that |seeks |to |reduce/prevent |the |negative |consequences |of | substance |us |and |improve |health |without |judgement, |coercion, |discrimination, |and |without |requiring | the |person |to |stop |using |the |substance Misuse |- |answersUsing |the |drug |in |ways |or |amounts |other |than |what |is |prescribed |or |goes |against | social |norms What |are |the |five |factors |that |contribute |to |the |potential |for |misuse |of |a |drug? |- |answers1. |Nature |of |the |drug
  1. |Route |of |administration: |routes |with |rapid |absorption |have |greater |potential
  2. |Amount/frequency |of |use
  3. |Availability
  4. |Inherent |harmfulness Which |drug |class |doesn't |have |withdrawal? |- |answersHallucinogens |(EX: |LSD) Name | 2 |amphetamine-related |compounds |- |answers- |methylphenidate |(Ritalin): |for |ADHD
  • |MDMA |(ecstasy) Amphetamine's |four |main |effects |within |the |CNS |- |answers1. |Decreased |threshold |for |transmitting | sensory |input |to |the |cerebral |cortex, |leading |to |CNS |excitation
  1. |A |feeling |of |euphoria |and |reward
  2. |Temperature-regulation |and |feeding |center |modifications |leading |to |appetite |suppression
  3. |Increase |in |aggressive |behaviour |and |mood |swings Amphetamine's |long |term |use |effects |- |answers- |chronic |sleeping |problems
  • |poor |appetite
  • |anxiety, |repetitive |behaviour, |psychoses, |aggressive |behaviour
  • |elevated |blood |pressure |and |abnormal |cardiac |rhythm What |are |two |therapeutic |uses |of |amphetamines? |- |answers- |narcolepsy
  • |ADHD Is |cocaine |a |CNS |stimulant? |- |answersYes

Duration |of |action |of |amphetamines |- |answersUp |to | 12 |hours Duration |of |action |of |cocaine |- |answersLess |than | 1 |hour Cocaine |inhibits |the |active |re-uptake |of |primarily |_______ |and |_________serotonin |into |the | presynaptic |neuron |- |answersDopamine |and |serotonin Does |cocaine |cause |a |generalized |CNS |stimulation |in |a |dose-dependent |manner? |- |answersYes What |is |the |only |therapeutic |use |of |cocaine? |- |answersLocal |anesthetic |for |the |mouth |and |throat Effects |of |long |term |use |of |cocaine |- |answers- |toxic |psychosis

  • |hallucinations, |sensations |of |insects |crawling |under |the |skin
  • |impaired |sexual |function
  • |permanent |brain |damage/impairment |of |neuronal |function |
  • |high |blood |pressure/irregular |heart |rhythm
  • |changes |to |nasal |mucosa True |or |false? |Nicotine |is |absorbed |rapidly |when |inhaled. |- |answersTrue What |is |the |half |life |of |nicotine? |- |answersAbout | 2 |hours What |receptors |does |nicotine |stimulate |at |the |synapses? |- |answersNicotinic Activation |of |nicotinic |receptors |increases |________. |- |answers- |psychomotor |activity
  • |cognitive |function
  • |attentions
  • |memory Short |term |effects |of |smoking |in |a |regular |smoker |- |answers- |mild |euphoria
  • |enhanced |arousal
  • |increased |ability |to |concentrate
  • |sense |of |relaxation
  • |increase |in |heart |rate |and |blood |pressure
  • |suppress |appetite Short |term |effects |of |smoking |in |a |non-regular |smoker |- |answers- |dizziness
  • |headache
  • |nausea
  • |vomiting

What |is |the |use |of |blood |doping |and |erythropoietin |in |sports? |- |answersIncrease |red |blood |cells | (circulation) How |is |blood |doping |detected? |- |answersMeasuring |the |age |of |red |blood |cells How |is |erythropoietin |detected? |- |answersTesting |urine |for |the |presence |of |recombinant | erythropoietin How |are |diuretics |used |in |sports? |- |answersReduce |body |water |so |the |athlete |can |compete |in |a |lower |weight |class Are |sedative-hypnotic |agents |CNS |stimulants |or |depressants? |- |answersDepressants What |are |the |doses |of |sedative-hypnotic |doses? |- |answers- |anti-anxiety: |for |anxiety |disorders

  • |sedation: |relieve |anxiety, |decrease |activate, |generally |calm |the |individual
  • |hypnosis: |sleep |by |producing |drowsiness
  • |general |anesthesia: |for |induced |anesthesia Some |therapies |aim |to |depress |overall |brain |activity. |By |doing |what? |- |answersBy |decreasing | glutamate-induced |nerve |firing How |does |GABA |inhibit? |- |answersBy |binding |to |and |selectively |opening |chloride |channels |that |are | built |of |multiple |subunits |that |span |the |neuronal |cell |membrane, |allowing |chloride |ions |to |flow |into | the |cell |when |signalled |to |open. |The |influx |of |chloride |ions |makes |it |harder |for |the |postsynaptic | neuron |to |transmit |incoming |messages |to |other |neurons |(depressing |CNS |neuronal |signalling). Does |each |sedative-hypnotic |bind |a |different |site |on |the |chloride |channel? |- |answersYes What |is |the |most |common |route |of |administration |of |benzodiazepines? |- |answersCapsule/tablet What |is |benzodiazepine's |mechanism |of |action? |- |answersActivation |of |the |benzodiazepine |receptor | increases |the |frequency |of |the |opening |of |the |chloride |channel Therapeutic |effects |of |benzodiazepines |- |answers- |relaxation, |calmness, |relied |from |anxiety
  • |skeletal |muscle |relaxation |and |have |anticonvulsant |effects
  • |minimal |REM-type |sleep What |type |of |therapeutic |index |do |benzodiazepines |have? |- |answersVery |high Antidote |for |benzodiazepines |- |answersFlumazenil Short |term |use |adverse |effects |of |benzodiazepines |- |answers- |CNS: |drowsiness, |lethargy, |fatigue, | impairment |of |thinking/memory
  • |breathing: |respiratory |depressions
  • |motor |coordination Long |term |use |adverse |effects |of |benzodiazepines |- |answers- |impaired |thinking
  • |poor |memory |and |judgement
  • |disorientation
  • |slurred |speech What |are |the |special |populations |that |receive |adverse |effects |of |benzodiazepine |use? |- |answers- | pregnant: |can |cross |the |placenta |and |go |into |the |fetus
  • |older |adults: |can |produce |cognitive |dysfunction |(bcuz |its |metabolized |slower) Misuse |and |SUD |of |benzodiazepine |- |answers- |misuse |potential: |low
  • |tolerance: |possible |but |not |rly |a |crazy |amount
  • |withdrawal: |mild |(anxiety, |headache, |insomnia)
  • |addiction: |possible What |are |barbiturates? |- |answersAnother |class |of |sedative |hypnotics How |are |barbiturates |classified? |- |answersAccording |to |their |duration |of |action
  • |long: |1-2 |days
  • |short: |3-8 |hours
  • |ultra |short: | 20 |mins What |is |the |route |of |administration |for |barbiturates |to |treat |epilepsy? |- |answersOral What |is |the |route |of |administration |for |barbiturates |for |anesthesia? |- |answersIntravenous What |are |barbiturate's |mechanism |of |action? |- |answersActivation |of |the |barbiturate |receptor | increases |the |duration |of |the |opening |of |the |chloride |channel Do |barbiturates |demonstrate |the |full |spectrum |of |dose-dependent |CNS |depression? |- |answersYes What |is |the |spectrum |of |dose-dependent |CNS |depression? |- |answersAnti-anxiety |—> |sedation |—> | hypnosis |—> |general |anesthesia |—> |death What |is |the |therapeutic |index |of |barbiturates? |- |answersLow What |is |the |antidote |for |barbiturates? |- |answersThere |is |no |antidote Do |barbiturates |suppress |REM-type |sleep? |- |answersYes Short |term |use |adverse |effects |of |barbiturates |- |answers- |mild |euphoria |and |reduced |interest |in | surroundings
  • |dizziness, |mild |impairment |of |motor |coordination |(esp |fine |motor |dexterity)
  • |depress |the |cardiovascular |system
  1. |Or |MEOS |when |there's |high |doses |of |ethanol
  2. |Acetaldehyde |to |acetate |by |ALDH
  3. |Acetate |to |carbon |dioxide |and |water What |is |the |rate |limiting |step |of |alcohol |metabolism |- |answersADH Enzymes |in |alcohol |metabolism |- |answersADH, |ALDH, |MEOS What |is |the |mechanism |of |action |of |alcohol? |- |answersBy |binding |to |the |chloride |ion |channel |and | increasing |GABA-mediated |neuronal |inhibition Short |term |use |effects |of |alcohol |in |low |doses |- |answersCardiovascular: |flushing |of |the |vessels |to |the | skin Stomach: |increased |gastric |secretion Liver: |none Short |term |use |effects |of |alcohol |in |high |doses |- |answersCardiovascular: |depress |the |cardiovascular | system, |altering |the |normal |heart |rhythm Stomach: |irritation |of |stomach |lining, |causing |inflammation |and |erosion |(vomiting |may |occur) Liver: |inhibit |glucose |production What |are |the |effects |of |alcohol |use |during |pregnancy? |- |answers- |teratogenic |effects |in |the |fetus, | leading |to |Fetal |Alcohol |Spectrum |Disorder |(FASD) What |drug |is |used |for |alcohol |use |disorder? |- |answersNaltrexone What |is |the |most |potent |psychoactive |agent |in |cannabinoids? |- |answersTHC What |year |did |recreational |cannabis |become |legal |in |Canada? |- |answers What |are |the |cannabinoid |receptors? |- |answersCB1: |in |the |brain CB2: |outside |the |CNS Mechanism |of |action |of |cannabis |- |answersWhen |CB1 |is |activated |by |anandamide |or |THC, |it |inhibits | the |release |of |excitatory |neurotransmitters, |explaining |the |cognitive |function |and |depressant |effects What |is |anandamide? |- |answersAn |endogenous |ligand |for |CB |receptors |involved |in |learning |and | memory |processes Half-life |of |cannabis |- |answers30 |hours Short |term |cannabis |use |effects |- |answersCNS: |relaxation/drowsiness, |well-being |and |euphoria, | increased |motor |coordination, |increased |appetite Cardiovascular: |increased |heart |rate, |increased |blood |flow |to |the |extremities, |postural |hypotension GI |tract: |increased |appetite, |dryness |of |the |mouth |and |throat

Other: |reduction |of |male |sex |drive Cannabis |withdrawal |symptoms |- |answers- |sleep |disturbances

  • |irritability
  • |loss |of |appetite
  • |nervousness
  • |mild |agitation
  • |upset |stomach
  • |sweating Classes |of |opioids |- |answers1. |Endogenous: |made |in |the |body |and |exert |analgesic |effects
  1. |Natural |(morphine): |not |made |by |the |human |body
  2. |Semi-synthetic: |slightly |altered |versions |of |morphine
  3. |Synthetic: |chemically |synthesized |to |bind |to |the |opioid |receptors 3 |families |of |endogenous |opioids |- |answersendorphins, |enkephalins, |dynorphins Effect |of |each |class |of |opioid |- |answersEndogenous: |affects |the |perception |of |pain |and |the |emotional | response |to |pain Natural: |used |clinically |to |treat |severe |acute.chronic |pain |and |can |cause |euphoria Semi-synthetic: |used |for |clinical |therapies 2 |types |of |natural |opioids |- |answers1. |Morphine: |treats |chronic |pain |and |binds |directly |to |opioid | receptors
  4. |Codeine: |10x |stronger |than |morphine 2 |types |of |semi-synthetic |opioids |- |answers- |hydromorphine: |5x |more |potent |than |morphine |and | used |for |analgesia
  • |diacetylmorphine |(heroin): |an |injectable |therapy |about |2-5x |more |potent Fentanyl |- |answers- |synthetic |opioid
  • |100x |more |potent |than |morphine
  • |designed |to |treat |pain Loperamide |- |answers- |synthetic |opioid
  • |side |effects: |consipation
  • |prevents |illicit |use, |as |it |does |not |cause |analgesia |or |euphoria Methadone |- |answers- |synthetic |opioid |used |for |analgesia
  • |maintains |the |cell |shape |and |integrity
  • |prevents |cell |lysis |from |high |osmotic |pressure What |is |the |difference |between |gram-positive |and |gram-negative |bacteria? |- |answersGram-positive | have |a |thick |peptidoglycan |layer |and |no |outer |membrane Gram-negative |have |a |thin |peptidoglycan |layer |and |an |outer |membrane What |are |the |two |spectrums |that |antibiotics |are |classified? |- |answersNarrow |spectrum |and |broad | spectrum What |is |narrow |spectrum |useful |against? |- |answersParticular |species |of |microorganisms What |is |broad |spectrum |useful |against? |- |answersA |wide |range |of |microorganisms, |including |gram- positive |and |gram-negative What |are |the |classifications |of |bacteria |that |target |the |biochemical |pathways? |- |answers Antibiotic |- |answersA |chemical |substance |that |suppresses |the |growth |of |bacteria, |and |may |eventually |destroy |them Are |antibiotics |produced |by |microorganisms |or |by |synthetic |compounds? |- |answersmicroorganisms What |is |the |purpose |of |an |antibiotic? |- |answersto |stop |a |bacterial |infection unlike |human |cells, |bacterial |cells |have |a |rigid |outer |layer |called |the |________, |which |completely | surrounds |the |__________. |- |answerscell |wall cytoplasmic |membrane what |is |a |peptidoglycan |layer? |- |answersan |element |of |the |cell |wall |that |is |a |complex, |cross-linked | polymer |of |polysaccharides |and |polypeptides gram-positive |vs |gram-negative |- |answers- |gram |positive |have |a |thick |peptidoglycan |layer |and |no | outer |membrane
  • |gram |negative |have |a |thin |peptidoglycan |layer |and |an |outer |membrane what |are |the |classifications |of |antibiotics |by |spectrum? |- |answersnarrow: |useful |against |particular | microorganism |species broad: |effective |against |a |wider |range |of |microorganisms, |including |gram-positive |and |gram-negative what |are |the |classifications |of |antibiotics |by |biochemical |pathway? |- |answers- |cell |wall |synthesis | inhibitors: |stop |the |proper |formation |of |the |bacterial |cell |wall |and/or |membrane, |influencing |the | structural |integrity |of |the |cell
  • |DNA |synthesis |inhibitors: |inhibit |DNA |replication |in |bacteria, |preventing |bacterial |growth
  • |protein |synthesis |inhibitors: |inhibit |protein |translation |within |bacteria |and |thereby |protein |synthesis
  • |metabolic |inhibitors: |block |the |formation |of |key |bacterial |metabolic |substrates |needed |for |bacteria | to |survive |and |reproduce

an |example |of |cell |wall |synthesis |inhibitors |- |answerspenicillins |and |cephalosporins an |example |of |DNA |synthesis |inhibitors |- |answersfluoroquinolones an |example |of |protein |synthesis |inhibitors |- |answerstetracyclines an |example |of |metabolic |inhibitors |- |answersantifolaxe |drugs who |successfully |isolated |penicillin? |- |answersFlorey |and |Chain what |are |the |two |types |of |penicillins |that |exist? |- |answers- |natural |(EX: |penicillin |G)

  • |semisynthetic |(EX: |modified |penicillin |G) describe |penicillin |G |- |answers- |narrow |spectrum |antibiotic |that |destroys |gram-positive |bacteria
  • |treats |pneumonia, |middle |ear |infections, |skin |infections, |and |meningitis
  • |treats |syphillis describe |methicillin |- |answers- |an |antibiotic |resistant |to |attack |by |penicillinase |(an |enzyme |that |is | resistant |to |penicillin |G |and |breaks |down |penicillin) describe |ampicillin |and |amoxicillin |- |answers- |broad |spectrum |(more |than |penicillin |G)
  • |useful |against |gram-negative |bacteria |
  • |treat |UTI describe |the |combination |of |amoxicillin |and |cavulanic |acid |- |answersa |combination |of |a |semisynthetic |penicillin |and |an |inhibitor |of |penicillinase |to |combat |penicillinase-producing |strains |of |bacteria describe |the |mechanism |of |action |of |penicillin |- |answers- |penicillin |is |closely |related |to |D-alanyl-D- alanine, |which |is |a |chemical |needed |for |the |formation |of |new |cell |walls
  • |penicillin |interferes |with |new |bacterial |cell |wall |formation |and |the |resulting |cells |are |formed | without |cell |walls |(these |are |protoplasts)
  • |humans |do |not |have |cell |walls |and |are |thus |unaffected |by |penicillin what |is |the |most |common |adverse |effect |of |penicillin |- |answersGI |distress |(nausea, |diarrhea) |due |to | disturbances |of |healthy |gut |flora if |an |individual |is |allergic |to |one |penicillin |preparation, |are |they |allergic |to |other |penicillin | preparations? |- |answersyes what |are |common |manifestations |of |penicillin |allergy |- |answersrash fever face |and |tongue |swelling itchy |hives

what |is |the |combination |product |of |sulfamethoxazole |and |trimethoprim? |- |answersco-trimoxazole, | which |treats |UTI, |respiratory |tact |infections, |and |GI |tract |infections when |should |antibiotics |be |used |in |combination? |- |answers- |to |treat |a |severe |infection |where |the | microorganism |is |not |known |or |the |infection |is |extremely |dangerous

  • |to |treat |an |infection |where |no |single |antibiotic |could |eliminate |all |the |different |bacteria |responsible
  • |to |treat |tuberculosis
  • |if |the |antibiotics |act |synergistically what |are |the |two |major |factors |associated |with |the |development |of |antibiotic |resistance? |- |answers- | evolution |of |bacteria
  • |clinical |and |environmental |factors what |are |the |causes |of |antibiotic |resistance? |- |answers- |over-prescription
  • |inappropriate |use
  • |use |in |agriculture will |antibiotics |help |the |flu |or |the |common |cold? |- |answersno; |these |are |caused |by |viruses |not | bacteria what |are |the |four |basic |mechanisms |for |how |organisms |become |resistant? |- |answersuptake: |small | molecules |gain |access |to |the |inside |of |the |microorganism |by |moving |through |pores |in |the | membranes target: |a |mutation |in |the |target |for |the |antibiotic |can |reduce |the |binding |of |the |drug |to |its |target |and |be |ineffective inactivation: |microorganisms |develop |an |enzyme |that |activates |the |antibiotic efflux |pumps: |some |microorganisms |will |over |express |transporters |that |pump |the |drug |out |of |the | microorganism |before |the |cell |can |be |injured describe |echinocandins |- |answers- |a |class |of |antifungals -act |by |inhibiting |the |synthesis |of |a |component |of |the |cell |wall, |resulting |in |disruption |of |the |cell |wall | and |fungal |death
  • |well |tolerated |by |patients
  • |only |available |for |IV |administration describe |imidazoles |- |answers- |effective |when |taken |orally |or |intravenously
  • |inhibit |a |fungal |cytochrome |P450, |which |inhibits |wegosterol |synthesis what |are | 2 |cell |wall |inhibitors |- |answersmicofungin caspofungin what |are | 3 |ergosterol |synthesis |inhibitors |- |answersketoconazole fluconazole miconazole virus |- |answersa |small, |infectious |agent |that |is |only |able |to |multiply |within |the |living |cells |of |other | organisms, |including |animals, |plants, |and |bacteria describe |oseltamivir |(tamiflu) |- |answers- |a |neuraminidase |inhibitor |that |treats |influenza
  • |neuraminidase |is |an |enzyme |that |allows |the |spread |of |the |virus |from |cell |to |cell
  • |it |prevents |neighbouring |cells |from |being |infected |with |the |virus describe |acyclovir |- |answers- |taken |up |into |infected |cells |and |the |virus |activates |acyclovir |to |the | active |form
  • |active |acyclovir |inhibits |viral |DNA |replication
  • |treats |herpes, |chickenpox, |shingles what |is |the |major |difference |between |antivirals |and |vaccines? |- |answers- |vaccines |introduce |non- functional |fragments |of |the |virus |to |the |body |prior |to |viral |infections
  • |so, |vaccines |are |preventative, |while |antivirals |treat |infections |that |are |already |in |the |body what |are |the | 3 |mechanisms |of |action |of |hormonal |contraceptives? |- |answers- |inhibit |hormone | release: |inhibit |the |release |of |gonadotropin-release |hormone |(GnRH) |from |the |hypothalamus, | meaning |the |pituitary |is |not |stimulated |to |release |FSH |and |LH, |resulting |in |no |follicular |maturation | and |the |inhibition |of |ovulation
  • |inhibit |sperm |migration: |hormonal |contraceptives |commonly |include |progestins, |which |alter |the | secretion |of |the |endocervical |gland |to |a |scant, |thick |fluid |not |optimal |for |sperm |migration
  • |inhibit |ovum |implantation: |causes |the |endometrium |to |not |fully |develop |making |it |unsuitable |for | implantation |of |a |fertilized |ovum what |is |an |oral |contraceptive? |- |answersa |product |containing |both |an |estrogen |and |a |progestin what |are |the | 3 |types |of |oral |contraceptives |- |answersfixed |combination multiphasic progestin |only